Stock SIOX SIO GENE THERAPIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sio Gene Therapies Inc. Nasdaq

Equities

SIOX

US8293991043

Delayed Nasdaq
Other stock markets
 03:58:58 2024-02-07 pm EST 		5-day change 1st Jan Change
0.478 USD +1.70% Intraday chart for Sio Gene Therapies Inc. +22.88% +29.19%
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from S&P TMI Index CI
2023 Sio Gene Therapies Inc.(OTCPK:SIOX) dropped from NASDAQ Composite Index CI

Business Summary

Sio Gene Therapies Inc. was a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. The Company has not generated any revenue.

Managers

Managers TitleAgeSince
David Nassif CEO
 Chief Executive Officer 70 19-06-30
Raquel Crystal COO
 Chief Operating Officer - -

Members of the board

Members of the board TitleAgeSince
David Nassif CEO
 Chief Executive Officer 70 19-06-30

Company contact information

Sio Gene Therapies, Inc.

1501 Broadway 12th floor

10036, New York

+877 746 4891

http://www.siogtx.com
address Sio Gene Therapies Inc.(SIOX)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. SIOX Stock
  4. SIOX Stock
  5. Company Sio Gene Therapies Inc.